Mesenchymal Stem Cell-Derived Exosomes: Emerging as a Promising Cell-Free Therapeutic Strategy for Autoimmune Hepatitis
Biomolecules · 24.10.2024 · 14 (11) · 1353
DOI: 10.3390/biom14111353 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Biomolecules, online erschienen am 24.10.2024. Verfasst von Liwen Wu und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Immunology, Zunyi Medical University, Zunyi 563003, China. Hauptthemen laut MEDLINE: Exosomes, Hepatitis, Autoimmune, Mesenchymal Stem Cells. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 123 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, the Collaborative Innovation Center of the Chinese Ministry of Education, Guizhou Provincial Natural Science Foundation.
Abstract (Originalsprache)
Autoimmune hepatitis (AIH) is an immune-mediated liver disease that currently faces limited treatment options. In its advanced stages, AIH can progress to liver fibrosis and cirrhosis. Recent research has increasingly focused on cell-free therapies, particularly the use of mesenchymal stem cell (MSC)-derived exosomes (Exos), which have shown promise in treating autoimmune diseases, including AIH. MSC-Exos, as microvesicles with low immunogenicity, high safety, and permeability, can deliver RNA, DNA, proteins, lipids, and various drugs for disease treatment, showing promising clinical application prospects. This review provides a comprehensive summary of the current research on MSC-Exos in the treatment of autoimmune hepatitis (AIH) and explores the underlying molecular mechanisms involved. It highlights the significant regulatory effects of MSC-Exos on immune cells and their ability to modify the microenvironment, demonstrating anti-inflammatory and anti-fibrotic properties while promoting liver regeneration. Additionally, this review also discusses potential challenges and future strategies for advancing Exo-based therapies in the treatment of AIH.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Immunology, Zunyi Medical University, Zunyi 563003, China.
- Collaborative Innovation Center of Tissue Damage Repair and Regeneration Medicine, Zunyi Medical University, Zunyi 563000, China.
- Scientific Research Center, The Third Affiliated Hospital of Zunyi Medical University, Zunyi 563003, China.
ORCID-Profile: Xianyao Wang
Förderung
- National Natural Science Foundation of China
- the Collaborative Innovation Center of the Chinese Ministry of Education
- Guizhou Provincial Natural Science Foundation
- Science and Technology Plan Project of Guizhou Province
- Collaborative Innovation Center of the Chinese Ministry of Education
Zitieren
APA
Wu, L., Zhang, L., Huang, M., Wu, Y., Jin, S., Zhang, Y., Gan, X., Yu, T., Yu, G., Zhang, J., & Wang, X. (2024). Mesenchymal Stem Cell-Derived Exosomes: Emerging as a Promising Cell-Free Therapeutic Strategy for Autoimmune Hepatitis. Biomolecules, 14(11), 1353. https://doi.org/10.3390/biom14111353
Vancouver
Wu L, Zhang L, Huang M, Wu Y, Jin S, Zhang Y, et al. Mesenchymal Stem Cell-Derived Exosomes: Emerging as a Promising Cell-Free Therapeutic Strategy for Autoimmune Hepatitis. Biomolecules. 2024;14(11):1353. doi:10.3390/biom14111353
BibTeX
@article{Wu2024,
author = {Wu, Liwen and Zhang, Longze and Huang, Minglei and Wu, Yan and Jin, Sikan and Zhang, Yaqi and Gan, Xinyun and Yu, Ting and Yu, Guang and Zhang, Jidong and Wang, Xianyao},
title = {Mesenchymal Stem Cell-Derived Exosomes: Emerging as a Promising Cell-Free Therapeutic Strategy for Autoimmune Hepatitis},
journal = {Biomolecules},
year = {2024},
volume = {14},
number = {11},
pages = {1353},
doi = {10.3390/biom14111353}
}
EUVIMED